These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37091151)

  • 1. Identification and verification of prognostic cancer subtype based on multi-omics analysis for kidney renal papillary cell carcinoma.
    Wang B; Li M; Li R
    Front Oncol; 2023; 13():1169395. PubMed ID: 37091151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioinformatic analysis highlights SNHG6 as a putative prognostic biomarker for kidney renal papillary cell carcinoma.
    Liu Y; Cheng X; Xi P; Zhang Z; Sun T; Gong B
    BMC Urol; 2023 Apr; 23(1):54. PubMed ID: 37004005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of anoikis-related gene PLK1 in kidney renal papillary cell carcinoma: a bioinformatics analysis and preliminary verification on promoting proliferation and migration.
    Gan L; Xiao Q; Zhou Y; Fu Y; Tang M
    Front Pharmacol; 2023; 14():1211675. PubMed ID: 37456749
    [No Abstract]   [Full Text] [Related]  

  • 4. Multidimensional Analyses of Tumor Immune Microenvironment Reveal the Possible Rationality of Immunotherapy and Identify High Immunotherapy Response Subtypes for Renal Papillary Cell Carcinoma.
    Wei B; Yu M; Yao J; Jiang M; An J; Yang J; Lin J; Zhao Y; Zhu Y
    Front Immunol; 2021; 12():657951. PubMed ID: 34531849
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comprehensive analysis of
    Bai J; Zheng A; Ha Y; Xu X; Yu Y; Lu Y; Zheng S; Shen Z; Luo B; Jie W
    Front Mol Biosci; 2022; 9():988777. PubMed ID: 36188228
    [No Abstract]   [Full Text] [Related]  

  • 6. PYCR in Kidney Renal Papillary Cell Carcinoma: Expression, Prognosis, Gene Regulation Network, and Regulation Targets.
    Shao Z; Lu L; Cui Y; Deng L; Xu Q; Liang Q; Lu X; Zhang J; Chen J; Situ Y
    Front Biosci (Landmark Ed); 2022 Dec; 27(12):336. PubMed ID: 36624948
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CTHRC1 Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Kidney Renal Papillary Cell Carcinoma and Kidney Renal Clear Cell Carcinoma.
    Zhou F; Shen D; Xiong Y; Cheng S; Xu H; Wang G; Qian K; Ju L; Zhang X
    Front Oncol; 2020; 10():570819. PubMed ID: 33628726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network diffusion-based approach for survival prediction and identification of biomarkers using multi-omics data of papillary renal cell carcinoma.
    Shetty KS; Jose A; Bani M; Vinod PK
    Mol Genet Genomics; 2023 Jul; 298(4):871-882. PubMed ID: 37093328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. System analysis of
    Situ Y; Xu Q; Deng L; Zhu Y; Gao R; Lei L; Shao Z
    Int J Biol Markers; 2022 Mar; 37(1):90-101. PubMed ID: 34870494
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ferroptosis-Related lncRNA to Predict the Clinical Outcomes and Molecular Characteristics of Kidney Renal Papillary Cell Carcinoma.
    Gong Y; Zhang C; Li H; Yu X; Li Y; Liu Z; He R
    Curr Issues Mol Biol; 2024 Feb; 46(3):1886-1903. PubMed ID: 38534739
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a novel defined inflammation-related long noncoding RNA signature contributes to predicting prognosis and distinction between the cold and hot tumors in bladder cancer.
    Xiong X; Chen C; Li X; Yang J; Zhang W; Wang X; Zhang H; Peng M; Li L; Luo P
    Front Oncol; 2023; 13():972558. PubMed ID: 37064115
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Analyses of Mutation-Derived Long-Chain Noncoding RNA Signatures of Genome Instability in Kidney Renal Papillary Cell Carcinoma.
    Li J; Wei S; Zhang Y; Lu S; Zhang X; Wang Q; Yan J; Yang S; Chen L; Liu Y; Huang Z
    Front Genet; 2022; 13():874673. PubMed ID: 35547247
    [No Abstract]   [Full Text] [Related]  

  • 13. Multi-omics analysis reveals prognostic value of tumor mutation burden in hepatocellular carcinoma.
    Xu Q; Xu H; Deng R; Wang Z; Li N; Qi Z; Zhao J; Huang W
    Cancer Cell Int; 2021 Jul; 21(1):342. PubMed ID: 34217320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular subtype classification of papillary renal cell cancer using miRNA expression.
    Yu C; Dai D; Xie J
    Onco Targets Ther; 2019; 12():2311-2322. PubMed ID: 31015763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of two heterogeneous subtypes of hepatocellular carcinoma with distinct pathway activities and clinical outcomes based on gene set variation analysis.
    Jin Z; Wang X; Zhang X; Cheng S; Liu Y
    Front Genet; 2024; 15():1441189. PubMed ID: 39323867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Construction and Analysis of lncRNA-miRNA-mRNA ceRNA Network Identify an Eight-Gene Signature as a Potential Prognostic Factor in Kidney Renal Papillary Cell Carcinoma (KIRP).
    Yang L; Ma TJ; Zhang YB; Wang H; An RH
    Altern Ther Health Med; 2022 Sep; 28(6):42-51. PubMed ID: 35648698
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cuproptosis-related lncRNA signatures predict prognosis and immune relevance of kidney renal papillary cell carcinoma.
    Xie T; Liu B; Liu D; Zhou Y; Yang Q; Wang D; Tang M; Liu W
    Front Pharmacol; 2022; 13():1103986. PubMed ID: 36618928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic risk signature based on the expression of three m6A RNA methylation regulatory genes in kidney renal papillary cell carcinoma.
    Sun Z; Jing C; Xiao C; Li T; Wang Y
    Aging (Albany NY); 2020 Nov; 12(21):22078-22094. PubMed ID: 33177247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential biomarkers for predicting the overall survival outcome of kidney renal papillary cell carcinoma: an analysis of ferroptosis-related LNCRNAs.
    Wu Z; Huang X; Cai M; Huang P
    BMC Urol; 2022 Sep; 22(1):152. PubMed ID: 36104680
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immune depletion of the methylated phenotype of colon cancer is closely related to resistance to immune checkpoint inhibitors.
    Zhong C; Xie T; Chen L; Zhong X; Li X; Cai X; Chen K; Lan S
    Front Immunol; 2022; 13():983636. PubMed ID: 36159794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.